Published December 2019 | Version v1
Journal article Metadata-only

Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization

Creators

  • 1. Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York (United States)
  • 2. Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York (United States)
  • 3. Department of Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York (United States)

Description

With increasing use of radiation for hepatocellular carcinoma (HCC) through transarterial radioembolization (TARE) and stereotactic body radiation therapy (SBRT), there is concern for increased radiation-related complications when using SBRT after TARE. This study compares safety of SBRT after segmental TARE versus transarterial chemoembolization (TACE).

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2019.09.006;
PII
S0360301619337617;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
105
Journal Issue
5
Journal Page Range
p. 968-976
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
55057169
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
HEPATOMAS; LIVER; RADIOEMBOLIZATION; SAFETY
Descriptors DEC
BODY; BRACHYTHERAPY; CARCINOMAS; DIGESTIVE SYSTEM; DISEASES; GLANDS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; RADIOTHERAPY; THERAPY

Optional Information

Copyright
Copyright (c) 2019 Elsevier Inc. All rights reserved.